Literature DB >> 21603885

Expression, purification, and activity assay of peptide deformylase from Escherichia coli and Staphylococcus aureus.

Xuchun Che1, Jinwei Hu, Lijuan Wang, Zhifeng Zhu, Qiong Xu, Junqiang Lv, Zheng Fu, Yajun Sun, Jia Sun, Gang Lin, Rong Lu, Zhi Yao.   

Abstract

Peptide deformylase (PDF) is considered an attractive target for screening novel antibiotics. The PDF from Escherichia coli and Staphylococcus aureus are representative of the gram-negative species type of PDF (type I PDF) and the gram-positive species type of PDF (type II PDF), respectively. They could be used for screening broad-spectrum antibiotics. Herein, we cloned the def gene by PCR, inserted it into plasmid pET-22b-def, and transformed the plasmid into E. coli BL21 (DE3) cells, then the cells were induced by IPTG to express PDF. E. coli Ni(2+)-PDF was extracted and purified by ion-exchange chromatography and gel filtration chromatography. S. aureus PDFs were extracted and purified using the MagExtractor kit. The nickel form of S. aureus PDF was obtained by adding NiCl(2) to all reagents used for purification. Iron-enriched S. aureus PDF was obtained by adding FeCl(3) to the growth medium for E. coli BL21 (DE3) cells and adding FeCl(3) and catalase to all reagents used for purification. The activities of PDFs were analyzed, compared, and grouped according to the experimental conditions that produced optimal activity, and we used actinonin as an inhibitor of PDF and calculated the IC(50) value. We obtained high expression of E. coli and S. aureus PDF with high activity and stability. The function of PDFs was inhibited by actinonin in a dose-dependent manner. Results may be helpful for future mechanistic investigations of PDF as well as high-throughput screening for other PDF inhibitors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21603885     DOI: 10.1007/s11010-011-0874-6

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  16 in total

1.  Actinonin: an antibiotic substance produced by an actinomycete.

Authors:  J J GORDON; B K KELLY; G A MILLER
Journal:  Nature       Date:  1962-08-18       Impact factor: 49.962

2.  Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor.

Authors:  D Z Chen; D V Patel; C J Hackbarth; W Wang; G Dreyer; D C Young; P S Margolis; C Wu; Z J Ni; J Trias; R J White; Z Yuan
Journal:  Biochemistry       Date:  2000-02-15       Impact factor: 3.162

3.  Crystal structure of the Escherichia coli peptide deformylase.

Authors:  M K Chan; W Gong; P T Rajagopalan; B Hao; C M Tsai; D Pei
Journal:  Biochemistry       Date:  1997-11-11       Impact factor: 3.162

4.  Metalloprotease inhibitors GM6001 and TAPI-0 inhibit the obligate intracellular human pathogen Chlamydia trachomatis by targeting peptide deformylase of the bacterium.

Authors:  Amit Balakrishnan; Bhairavi Patel; Stephan A Sieber; Ding Chen; Niseema Pachikara; Guangming Zhong; Benjamin F Cravatt; Huizhou Fan
Journal:  J Biol Chem       Date:  2006-03-24       Impact factor: 5.157

5.  Peptide deformylase inhibitors as potent antimycobacterial agents.

Authors:  Jeanette W P Teo; Pamela Thayalan; David Beer; Amelia S L Yap; Mahesh Nanjundappa; Xinyi Ngew; Jeyaraj Duraiswamy; Sarah Liung; Veronique Dartois; Mark Schreiber; Samiul Hasan; Michael Cynamon; Neil S Ryder; Xia Yang; Beat Weidmann; Kathryn Bracken; Thomas Dick; Kakoli Mukherjee
Journal:  Antimicrob Agents Chemother       Date:  2006-09-11       Impact factor: 5.191

6.  Crystal structure of type II peptide deformylase from Staphylococcus aureus.

Authors:  Eric T Baldwin; Melissa S Harris; Anthony W Yem; Cindy L Wolfe; Anne F Vosters; Kimberly A Curry; Robert W Murray; Jeffrey H Bock; Vincent P Marshall; Joyce I Cialdella; Mahesh H Merchant; Gil Choi; Martin R Deibel
Journal:  J Biol Chem       Date:  2002-06-04       Impact factor: 5.157

Review 7.  Bacterial Peptide deformylase inhibitors: a new class of antibacterial agents.

Authors:  R Jain; D Chen; R J White; D V Patel; Z Yuan
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

8.  Structural variation and inhibitor binding in polypeptide deformylase from four different bacterial species.

Authors:  Kathrine J Smith; Chantal M Petit; Kelly Aubart; Martin Smyth; Edward McManus; Jo Jones; Andrew Fosberry; Ceri Lewis; Michael Lonetto; Siegfried B Christensen
Journal:  Protein Sci       Date:  2003-02       Impact factor: 6.725

9.  Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).

Authors:  Amy A Watters; Ronald N Jones; Jennifer A Leeds; Gerald Denys; Helio S Sader; Thomas R Fritsche
Journal:  J Antimicrob Chemother       Date:  2006-03-20       Impact factor: 5.790

10.  Characterization of a human peptide deformylase: implications for antibacterial drug design.

Authors:  Kiet T Nguyen; Xubo Hu; Craig Colton; Ratna Chakrabarti; Michael X Zhu; Dehua Pei
Journal:  Biochemistry       Date:  2003-08-26       Impact factor: 3.162

View more
  1 in total

1.  Identification of crucial amino acids of bacterial Peptide deformylases affecting enzymatic activity in response to oxidative stress.

Authors:  Sanjay Kumar; Pavitra Kanudia; Subramanian Karthikeyan; Pradip K Chakraborti
Journal:  J Bacteriol       Date:  2013-10-18       Impact factor: 3.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.